{"id":11229,"date":"2020-03-02T11:00:09","date_gmt":"2020-03-02T11:00:09","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=11229"},"modified":"2023-08-14T06:48:13","modified_gmt":"2023-08-14T06:48:13","slug":"myeloproliferative-disorder","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/","title":{"rendered":"Myeloproliferative disorder"},"content":{"rendered":"<p>Disease of the bone marrow in which excess cells are produced.<\/p>\n<hr \/>\n<p>A group of related and highly similar diseases that involve abnormally high production of certain kinds of blood cells because of malfunction of the bone marrow. The myeloproliferative diseases differ from one another in the primary type of blood cell affected. Normal bone marrow contains cells, known as hematopoietic cells or stem cells, that have the ability to reproduce themselves into what is known as a clone. Each clone can produce different cell lines that develop into red blood cells, one of several kinds of white blood cells, and platelets (cells that have key roles in blood clotting). In normal bone marrow, a number of clones are active in producing normal blood cells in normal proportions. In the myeloproliferative disorders, an abnormal clone takes over from the others, producing blood cells of one type that are essentially normal yet far too abundant, while the number of other blood cell types may be too low.<\/p>\n<hr \/>\n<p>Any of several hematologic malignancies marked by the excessive multiplication of one or more types of blood cells. These disorders include polycythemia rubra vera, essential thrombocytosis, chronic myeloid leukemia, and idiopathic myelofibrosis.<\/p>\n<hr \/>\n<div class=\"group w-full text-gray-800 dark:text-gray-100 border-b border-black\/10 dark:border-gray-900\/50 bg-gray-50 dark:bg-[#444654] sm:AIPRM__conversation__response\">\n<div class=\"flex p-4 gap-4 text-base md:gap-6 md:max-w-2xl lg:max-w-[38rem] xl:max-w-3xl md:py-6 lg:px-0 m-auto\">\n<div class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 md:gap-3 lg:w-[calc(100%-115px)]\">\n<div class=\"flex flex-grow flex-col gap-3\">\n<div class=\"min-h-[20px] flex flex-col items-start gap-4 whitespace-pre-wrap break-words\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light AIPRM__conversation__response\">\n<p>A hyperproliferative disorder of the bone marrow manifests when there is an excessive and rapid production of cells.<\/p>\n<hr \/>\n<div class=\"group w-full text-token-text-primary border-b border-black\/10 dark:border-gray-900\/50 bg-gray-50 dark:bg-[#444654]\">\n<div class=\"flex p-4 gap-4 text-base md:gap-6 md:max-w-2xl lg:max-w-[38rem] xl:max-w-3xl md:py-6 lg:px-0 m-auto\">\n<div class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 md:gap-3 lg:w-[calc(100%-115px)]\">\n<div class=\"flex flex-grow flex-col gap-3\">\n<div class=\"min-h-[20px] flex flex-col items-start gap-3 overflow-x-auto whitespace-pre-wrap break-words\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light AIPRM__conversation__response\">\n<p>Medical conditions distinguished by the abnormal growth of one or more groups of blood cells within the bone marrow.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Disease of the bone marrow in which excess cells are produced. A group of related and highly similar diseases that involve abnormally high production of certain kinds of blood cells because of malfunction of the bone marrow. The myeloproliferative diseases differ from one another in the primary type of blood cell affected. Normal bone marrow [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-11229","post","type-post","status-publish","format-standard","hentry","category-m"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Myeloproliferative disorder - Definition of Myeloproliferative disorder<\/title>\n<meta name=\"description\" content=\"Disease of the bone marrow in which excess cells are produced.A group of related and highly similar diseases that involve abnormally high production of certain kinds of blood cells because of malfunction of the bone marrow. The myeloproliferative diseases differ from one another in the primary type of blood cell affected. Normal bone marrow contains cells, known as hematopoietic cells or stem cells, that have the ability to reproduce themselves into what is known as a clone. Each clone can produce different cell lines that develop into red blood cells, one of several kinds of white blood cells, and platelets (cells that have key roles in blood clotting). In normal bone marrow, a number of clones are active in producing normal blood cells in normal proportions. In the myeloproliferative disorders, an abnormal clone takes over from the others, producing blood cells of one type that are essentially normal yet far too abundant, while the number of other blood cell types may be too low.Any of several hematologic malignancies marked by the excessive multiplication of one or more types of blood cells. These disorders include polycythemia rubra vera, essential thrombocytosis, chronic myeloid leukemia, and idiopathic myelofibrosis.A hyperproliferative disorder of the bone marrow manifests when there is an excessive and rapid production of cells.Medical conditions distinguished by the abnormal growth of one or more groups of blood cells within the bone marrow.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myeloproliferative disorder - Definition of Myeloproliferative disorder\" \/>\n<meta property=\"og:description\" content=\"Disease of the bone marrow in which excess cells are produced.A group of related and highly similar diseases that involve abnormally high production of certain kinds of blood cells because of malfunction of the bone marrow. The myeloproliferative diseases differ from one another in the primary type of blood cell affected. Normal bone marrow contains cells, known as hematopoietic cells or stem cells, that have the ability to reproduce themselves into what is known as a clone. Each clone can produce different cell lines that develop into red blood cells, one of several kinds of white blood cells, and platelets (cells that have key roles in blood clotting). In normal bone marrow, a number of clones are active in producing normal blood cells in normal proportions. In the myeloproliferative disorders, an abnormal clone takes over from the others, producing blood cells of one type that are essentially normal yet far too abundant, while the number of other blood cell types may be too low.Any of several hematologic malignancies marked by the excessive multiplication of one or more types of blood cells. These disorders include polycythemia rubra vera, essential thrombocytosis, chronic myeloid leukemia, and idiopathic myelofibrosis.A hyperproliferative disorder of the bone marrow manifests when there is an excessive and rapid production of cells.Medical conditions distinguished by the abnormal growth of one or more groups of blood cells within the bone marrow.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-02T11:00:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-14T06:48:13+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/\",\"name\":\"Myeloproliferative disorder - Definition of Myeloproliferative disorder\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-03-02T11:00:09+00:00\",\"dateModified\":\"2023-08-14T06:48:13+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Disease of the bone marrow in which excess cells are produced.A group of related and highly similar diseases that involve abnormally high production of certain kinds of blood cells because of malfunction of the bone marrow. The myeloproliferative diseases differ from one another in the primary type of blood cell affected. Normal bone marrow contains cells, known as hematopoietic cells or stem cells, that have the ability to reproduce themselves into what is known as a clone. Each clone can produce different cell lines that develop into red blood cells, one of several kinds of white blood cells, and platelets (cells that have key roles in blood clotting). In normal bone marrow, a number of clones are active in producing normal blood cells in normal proportions. In the myeloproliferative disorders, an abnormal clone takes over from the others, producing blood cells of one type that are essentially normal yet far too abundant, while the number of other blood cell types may be too low.Any of several hematologic malignancies marked by the excessive multiplication of one or more types of blood cells. These disorders include polycythemia rubra vera, essential thrombocytosis, chronic myeloid leukemia, and idiopathic myelofibrosis.A hyperproliferative disorder of the bone marrow manifests when there is an excessive and rapid production of cells.Medical conditions distinguished by the abnormal growth of one or more groups of blood cells within the bone marrow.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myeloproliferative disorder\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myeloproliferative disorder - Definition of Myeloproliferative disorder","description":"Disease of the bone marrow in which excess cells are produced.A group of related and highly similar diseases that involve abnormally high production of certain kinds of blood cells because of malfunction of the bone marrow. The myeloproliferative diseases differ from one another in the primary type of blood cell affected. Normal bone marrow contains cells, known as hematopoietic cells or stem cells, that have the ability to reproduce themselves into what is known as a clone. Each clone can produce different cell lines that develop into red blood cells, one of several kinds of white blood cells, and platelets (cells that have key roles in blood clotting). In normal bone marrow, a number of clones are active in producing normal blood cells in normal proportions. In the myeloproliferative disorders, an abnormal clone takes over from the others, producing blood cells of one type that are essentially normal yet far too abundant, while the number of other blood cell types may be too low.Any of several hematologic malignancies marked by the excessive multiplication of one or more types of blood cells. These disorders include polycythemia rubra vera, essential thrombocytosis, chronic myeloid leukemia, and idiopathic myelofibrosis.A hyperproliferative disorder of the bone marrow manifests when there is an excessive and rapid production of cells.Medical conditions distinguished by the abnormal growth of one or more groups of blood cells within the bone marrow.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/","og_locale":"en_US","og_type":"article","og_title":"Myeloproliferative disorder - Definition of Myeloproliferative disorder","og_description":"Disease of the bone marrow in which excess cells are produced.A group of related and highly similar diseases that involve abnormally high production of certain kinds of blood cells because of malfunction of the bone marrow. The myeloproliferative diseases differ from one another in the primary type of blood cell affected. Normal bone marrow contains cells, known as hematopoietic cells or stem cells, that have the ability to reproduce themselves into what is known as a clone. Each clone can produce different cell lines that develop into red blood cells, one of several kinds of white blood cells, and platelets (cells that have key roles in blood clotting). In normal bone marrow, a number of clones are active in producing normal blood cells in normal proportions. In the myeloproliferative disorders, an abnormal clone takes over from the others, producing blood cells of one type that are essentially normal yet far too abundant, while the number of other blood cell types may be too low.Any of several hematologic malignancies marked by the excessive multiplication of one or more types of blood cells. These disorders include polycythemia rubra vera, essential thrombocytosis, chronic myeloid leukemia, and idiopathic myelofibrosis.A hyperproliferative disorder of the bone marrow manifests when there is an excessive and rapid production of cells.Medical conditions distinguished by the abnormal growth of one or more groups of blood cells within the bone marrow.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/","og_site_name":"Glossary","article_published_time":"2020-03-02T11:00:09+00:00","article_modified_time":"2023-08-14T06:48:13+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/","name":"Myeloproliferative disorder - Definition of Myeloproliferative disorder","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-03-02T11:00:09+00:00","dateModified":"2023-08-14T06:48:13+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Disease of the bone marrow in which excess cells are produced.A group of related and highly similar diseases that involve abnormally high production of certain kinds of blood cells because of malfunction of the bone marrow. The myeloproliferative diseases differ from one another in the primary type of blood cell affected. Normal bone marrow contains cells, known as hematopoietic cells or stem cells, that have the ability to reproduce themselves into what is known as a clone. Each clone can produce different cell lines that develop into red blood cells, one of several kinds of white blood cells, and platelets (cells that have key roles in blood clotting). In normal bone marrow, a number of clones are active in producing normal blood cells in normal proportions. In the myeloproliferative disorders, an abnormal clone takes over from the others, producing blood cells of one type that are essentially normal yet far too abundant, while the number of other blood cell types may be too low.Any of several hematologic malignancies marked by the excessive multiplication of one or more types of blood cells. These disorders include polycythemia rubra vera, essential thrombocytosis, chronic myeloid leukemia, and idiopathic myelofibrosis.A hyperproliferative disorder of the bone marrow manifests when there is an excessive and rapid production of cells.Medical conditions distinguished by the abnormal growth of one or more groups of blood cells within the bone marrow.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/myeloproliferative-disorder\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Myeloproliferative disorder"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/11229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=11229"}],"version-history":[{"count":5,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/11229\/revisions"}],"predecessor-version":[{"id":237135,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/11229\/revisions\/237135"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=11229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=11229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=11229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}